Introduction: Adult-onset Still's disease, an auto-inflammatory disease, is well described in the literature and tends to respond well to IL-1 blockade. A sub-group of adult patients may present with some of the typical symptoms and findings whichare commonly associated with autoinflammatory conditionsbut may not fulfil the criteria to obtain aspecific diagnosis. It has been reported in the literature that these patients may represent an 'undifferentiated systemic autoinflammatory disorder' and case reports support the use of anakinra as a viable treatment option in this sub-group. Case description: A 54-year-old female presented to rheumatology in 2014 with a two year history of recurrent episodes of sore throat, pyrexia, night sweats, polyarthralgia, headaches and bilateral episcleritis. Each episode recurred monthly and lasted three to five days before resolving. This patient's condition did not fulfil Yamaguchi's criteria for adult-onset Still's disease. Investigations revealed an elevated ferritin which ranged between 500-2700, CRP greater than 300, ESR greater than 120. Extensive investigations excluded an infective or malignant cause and included virology, autoimmune and vasculitis screen, IGRA, blood cultures, transthoracic echo, ultrasound abdomen, CT chest/abdomen/pelvis and CT-PET scan. Genetic screening for hereditary autoinflammatory disorders was negative. Serum immunoglobulins (including IgD) and serum protein electrophoresis was unremarkable. The patient's symptoms and inflammatory markers were responsive to high dose oral prednisolone, however, her symptoms recurred with steroid tapering. The patient was commenced on Methotrexate 25mg once weekly by subcutaneous injection to facilitate steroid weaning in 2015. The patient initially responded well to Methotrexate and was successfully weaned off steroids completely, she remained asymptomatic for two years. In 2017, she experienced frequent flares of her condition and continued to have active episcleritis on ophthalmological assessment. The patient required multiple courses of oral prednisolone to control her regular flares. The decision was taken to commence the patient onanakinra 100mg once daily subcutaneous injections one year ago in combination with methotrexate. The patient's condition has remained in remission since commencing anakinra in 2018 with resolution of her symptoms, episcleritis and serum inflammatory markers and is nolonger requiring oral prednisolone. Discussion: This patient exhibited signs and symptoms which are commonly associated with auto-inflammatory conditions. Due to the clinical phenotypeand negativegenetic testing, this patient did not fulfil anycriteria to be diagnosed with a specific auto-inflammatory disease. She did not fulfil Yamaguchi's criteria for adult-onset Still's disease. It is likely that this patient represents a case of 'atypical adult-onset Still's disease' or an 'undifferentiated systemic autoinflammatory disorder' which is supported by herexcellent responseto IL-1 blockade in the form of anakinra. Key learning points: This case highlights the importance of considering 'undifferentiated systemic autoinflammatory disorder' or 'atypical adultonset Still's disease' as a potential diagnosis for the subgroup of patients presenting atypically who do not fulfil any current classification or diagnostic criteria for a specific autoinflammatory disease. This case also illustrates that IL-1 blockade is potentially a viable treatment option in these patients. Introduction: Autoinflammatory conditions can arise in patients presenting on the medical take. Patients presenting with an inflammatory response, fever and organ dysfunction are usually (and appropriately) managed as sepsis until proven otherwise. However, a suspicion should be maintained for alternative diagnoses when there is no improvement with conventional antimicrobial therapy. We present a case of a young woman presenting with polyserositis with a wide differential diagnosis including infection, autoimmunity and malignancy. She was treated successfully with colchicine. Subsequent genetic analysis at the Royal Free hospital for fever syndromes has not found a pre-described genetic polymorphism. Case description: A 39-year-old woman presented to A&E with dyspnoea,night sweats,lethargyandrightupperquadrantpain.Herpastmedical history included hypothyroidism and two years of intermittent diarrhoea. This diarrhoea was associated with a raised faecal calprotectin. Subsequent investigation with colonoscopy and MRI small bowel were normal. Other past history included pleurisy felt to be secondary to a lower respiratory tract infection aged 38 and a right knee effusion aged 15. She was born inthe UKbut had aGreekmother. Examination revealed reduced breath sounds in the bases which were dull to percuss, normal heart sounds and mild abdominal distension. There was no peripheral oedema. Observations showed oxygen saturations of 90% on air, BP 90/50, HR 120 and a pyrexia of 38 C. Blood results showed araised ALT of 100and CRP 40.She was initially treated withantibiotics for aworking diagnosis of atypical pneumonia. Her respiratory failure deteriorated and a CTPA two days later showed bilateral pleural effusions, a massive pericardial effusion with impending tamponade and a right upper lobe PE. A CT CAP show moderate ascites but noevidence of malignancy orlymphoma. Pericardiocentesis showed a reactive picture with no organisms grown and normal cytopathology of the fluid. Pleural and ascitic fluid were also drained and she was commenced on LMWH for the PE. Virology, microbiological and autoimmune screens were unremarkable. CRP at this stage had risen to78 as had the ALT to 1400. 6 days after admission, antibiotics were stopped shewas commenced on colchicine 1mg bd. Within 48 hours she rapidly improved both clinically and biochemically. Discussion:Since the index admission genetic analysis has shown sheis HLA B51 negative and she has no recognised genetic polymorphism associated with a periodic fever syndrome. 20 months since admission she has made a good recovery and is stable on colchicine 1mg od with no recurrence of the pleural and pericardial effusions. She has had one further episode of diarrhoea for 2 weeks associated with a raised faecal calprotectin and red macular rashes on her torso. Anticoagulation forthe PE hasbeen stopped. Polyserositis in the absence of infection or malignancy is uncommon and autoinflammatory and autoimmune aetiologies should be considered. This case highlights the importance of keeping a broad mind in patients presenting in an unusual way or when they do not respond to initial treatment. Autoinflammatory conditions are characterised by marked inflammation affecting the skin, serosal surfaces and synovium among others. Her history of colitis is intriguing. There are case reports of patients with familial Mediterranean fever presenting with serositis but she was negative for FMF on further genetic testing. Similarly she did not prove to have any of the genes that have so far been recognised as causing a periodic fever syndrome. We did considerBehc¸et's butshedenied ahistoryof recurrent oral orgenital ulceration or iritis and there was no family history. However Behc¸et's can lead to inflammatory bowel disease and this remains an intriguing possibility.
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